-
My Account
My Account
BSE Live
Apr 12, 10:58Prev. Close
8227.25
Open Price
8240.00
Bid Price (Qty.)
8151.45 (6)
Offer Price (Qty.)
8165.55 (2)
NSE Live
Apr 12, 10:58Prev. Close
8218.20
Open Price
8249.00
Bid Price (Qty.)
8151.70 (1)
Offer Price (Qty.)
8162.90 (23)
| Quarterly Results of Sanofi India (in Rs. Cr.) | Dec '20 | Sep '20 | Jun '20 | Mar '20 | Dec '19 | |
| Net Sales/Income from operations | 720.30 | 686.60 | 710.50 | 784.50 | 826.30 | |
| Other Operating Income | -- | -- | -- | -- | -- | |
| Total Income From Operations | 720.30 | 686.60 | 710.50 | 784.50 | 826.30 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 148.30 | 135.20 | 65.70 | 242.20 | 230.10 | |
| Purchase of Traded Goods | 160.90 | 159.20 | 165.90 | 118.70 | 122.70 | |
| Increase/Decrease in Stocks | 6.80 | -13.50 | 84.90 | -20.70 | 7.50 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 107.20 | 109.60 | 123.70 | 120.30 | 115.00 | |
| depreciat | 20.40 | 20.60 | 20.50 | 20.70 | 21.50 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 130.10 | 103.90 | 93.10 | 147.30 | 172.80 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 146.60 | 171.60 | 156.70 | 156.00 | 156.70 | |
| Other Income | 16.20 | 14.90 | 29.20 | 29.50 | 24.80 | |
| P/L Before Int., Excpt. Items & Tax | 162.80 | 186.50 | 185.90 | 185.50 | 181.50 | |
| Interest | 0.40 | 0.40 | 0.50 | 0.50 | 0.30 | |
| P/L Before Exceptional Items & Tax | 162.40 | 186.10 | 185.40 | 185.00 | 181.20 | |
| Exceptional Items | 7.80 | -0.20 | 1.10 | -50.40 | -19.90 | |
| P/L Before Tax | 170.20 | 185.90 | 186.50 | 134.60 | 161.30 | |
| Tax | 47.20 | 53.00 | 50.20 | 49.20 | 64.00 | |
| P/L After Tax from Ordinary Activities | 123.00 | 132.90 | 136.30 | 85.40 | 97.30 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 123.00 | 132.90 | 136.30 | 85.40 | 97.30 | |
| Equity Share Capital | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | |
| Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 53.41 | 57.71 | 59.18 | 37.08 | 42.26 | |
| Diluted EPS | 53.41 | 57.71 | 59.18 | 37.08 | 42.26 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 53.41 | 57.71 | 59.18 | 37.08 | 42.26 | |
| Diluted EPS. | 53.41 | 57.71 | 59.18 | 37.08 | 42.26 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
18.03.2021
26.02.2021
26.02.2021
Sanofi India Standalone December 2020 Net Sales at Rs 720.30 crore, down 12.83% Y-o-Y
25.02.2021
Sanofi India Standalone December 2020 Net Sales at Rs 720.30 crore, down 12.83% Y-o-Y
26.02.2021
Sanofi India Standalone December 2020 Net Sales at Rs 720.30 crore, down 12.83% Y-o-Y
25.02.2021
Sanofi India Standalone December 2020 Net Sales at Rs 720.30 crore, down 12.83% Y-o-Y
24.02.2021
Sanofi India Standalone December 2020 Net Sales at Rs 720.30 crore, down 12.83% Y-o-Y
29.10.2020
Sanofi India Standalone September 2020 Net Sales at Rs 686.60 crore, down 11.87% Y-o-Y
